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TSH level is the 
preferred test 
for both initial 
evaluation of 
suspected primary 
hypothyroidism 
and monitoring 
treatment
  
Which lab tests are best when 
you suspect hypothyroidism?
A reasonable approach, yes, 
but more data are needed
In my practice, some patients ask for more 
testing than necessary, whereas others 
can’t afford indicated interval lab tests. 
Ordering unnecessary screening tests or a 
batched thyroid panel is, too often, a simple 
but inappropriate clinician response. 
 Unfortunately, we must rely solely on 
expert opinion to guide laboratory testing for 
hypothyroidism. Nevertheless, the guidelines 
described in this Clinical Inquiry provide not 
only an appropriate algorithm for diagnosis, 
but also a logical basis on which to justify 
ongoing monitoring intervals.
 Inconsistent use of laboratory testing 
among health care providers can lead 
to misdiagnosis, inappropriate changes 
in treatment, patient confusion, and 
added cost. Given the high incidence of 
hypothyroidism, evidence-based decision 
making could help avoid unnecessary 
testing and wasteful expenditure.
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Clinical commentary
Thyroid-stimulating hormone (TSH) level 
is the preferred test for initial evaluation of 
suspected primary hypothyroidism (strength 
of recommendation [SOR]: C, expert 
opinion). If TSH is abnormal, a free thyroxine 
(T4) level will further narrow the diagnosis. 
Obtain a triiodothyronine (T3) level if TSH is 
undetectable and free T4 is normal. 
 When assessing the adequacy 
of replacement therapy in primary 
hypothyroidism, the TSH is the most 
important parameter to monitor (SOR: C, 
expert opinion). Because TSH levels can’t 
be used to monitor central hypothyroidism, 
use free T4 and T3 concentrations (SOR: C, 
case series).
Evidence-based answer
❚ Evidence summary
Hypothyroidism is a common condi-
tion, affecting 4.6% of the population 
in the United States, according to the 
National Health and Nutrition Ex-
amination Survey (NHANES III).1 A 
statewide study in Colorado found the 
prevalence of elevated TSH levels to be 
9.5%.2 The study population was old-
er and had more women, Caucasians, 
and high school and college graduates 
than the general population. Among the 
general population, the prevalence of 
unsuspected overt hypothyroidism has 
been reported to be 0 to 18 cases per 
1000.3
No randomized controlled trials 
or other high-quality studies have ad-
dressed the question of what labora-
tory tests are most useful to diagnose 
and monitor the treatment of hypothy-
roidism. 
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TSH is a cost-effective initial test, 
but has limitations
Experts recommend TSH level as the 
most cost-effective initial laboratory test 
for suspected primary hypothyroidism.4 
TSH had a high sensitivity (98%) and 
specifi city (92%) when used to confi rm 
thyroid disease in patients referred to a 
specialty endocrine clinic, but its positive 
predictive value is low when used as a 
screening test in primary care.5 
TSH is a poor measure of the clini-
cal severity of hypothyroidism. In one 
study, no correlation was found between 
serum TSH and clinical and metabolic 
markers—such as clinical score, ankle 
refl ex time, total cholesterol, and creatine 
kinase—when estimating the severity of 
primary thyroid failure.6 
Uses of free T4, T3, and imaging 
If TSH is elevated, a free T4 level can help 
differentiate between central hyperthy-
roidism and much more common periph-
eral hypothyroidism (99% of patients). 
A T3 level is necessary only if the TSH is 
undetectable and the free T4 is normal.
7,8 
Imaging the thyroid gland is reserved for 
evaluating structural abnormalities.
When to reassess TSH
In primary hypothyroidism, reassess 
TSH 6 weeks after the start of treat-
ment or a change in replacement dose.4 
This recommendation is based on the 
fact that levothyroxine has a half-life of 
about a week; a steady state would be 
achieved over the course of 5 half-lives. 
No direct patient-oriented evidence ex-
ists for this testing interval. Test free T4 
if you suspect excessive replacement or 
noncompliance. 
Once TSH is in the normal range, 
experts recommend assessing the level af-
ter 6 months and then annually.4 A 2005 
study suggested lowering the target TSH 
level for assessing adequate replacement 
in patients treated with standard levothy-
roxine because subtherapeutic T3 levels 
were found despite normal TSH levels in 
these patients.9
TSH can’t be used to monitor ther-
apy for central hypothyroidism. Follow 
both free T4 and T3 concentrations be-
cause elevated T3 levels, indicative of 
overtreatment, can occur even when free 
T4 measurements are normal in these 
patients.10 
Recommendations 
ACP Medicine recommends TSH as the 
initial test. If TSH is elevated, ACP Medi-
cine advises confi rmation with a repeat 
TSH plus a free T4.
11 ■
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Test free T4 if TSH 
is abnormal on 
initial evaluation; 
test T3 if TSH is 
undetectable and 
free T4 is normal 
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